These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1536391)

  • 1. Improvement of ultrasonographic and serologic changes in Schistosoma japonicum-infected patients after treatment with praziquantel.
    Ohmae H; Tanaka M; Hayashi M; Matsuzaki Y; Kurosaki Y; Blas BL; Portillo GG; Sy OS; Irie Y; Yasuraoka K
    Am J Trop Med Hyg; 1992 Jan; 46(1):99-104. PubMed ID: 1536391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasonographic and serologic abnormalities in Schistosoma japonicum infection in Leyte, the Philippines.
    Ohmae H; Tanaka M; Hayashi M; Matsuzaki Y; Kurosaki Y; Blas BL; Portillo GG; Sy OS; Irie Y; Yasuraoka K
    Am J Trop Med Hyg; 1992 Jan; 46(1):89-98. PubMed ID: 1536390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mini-review: the ultrasonographical and serological changes and their improvement after praziquantel treatment in Schistosoma japonicum infected patients in Leyte, Philippines.
    Tanaka M
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 4():277-80. PubMed ID: 1343908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serologic and ultrasonographic parameters of praziquantel treatment of hepatic fibrosis in Schistosoma japonicum infection.
    Ohmae H; Tanaka M; Nara T; Utsunomiya H; Taguchi H; Irie Y; Yasuraoka K
    Am J Trop Med Hyg; 1991 Sep; 45(3):350-9. PubMed ID: 1928570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of ultrasonography and two serum biochemical indices for hepatic fibrosis in schistosomiasis japonica patients one year after praziquantel treatment.
    Cai W; Chen Z; Chen F; Zhou C; Liu R; Wang J
    Chin Med J (Engl); 1997 Oct; 110(10):797-800. PubMed ID: 9642313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the period for establishment of a liver network echogenic pattern in Schistosoma japonicum infection.
    Chigusa Y; Otake H; Ohmae H; Kirinoki M; Ilagan EJ; Barzaga NG; Kawabata M; Hayashi M; Matsuda H
    Parasitol Int; 2006 Mar; 55(1):33-7. PubMed ID: 16216544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year impact of repeated praziquantel treatment on subclinical morbidity due to Schistosoma japonicum in China.
    Li YS; Sleigh AC; Li Y; Tanner M; Dessein A; Williams GM; McManus DP
    Trans R Soc Trop Med Hyg; 2002; 96(4):438-43. PubMed ID: 12497984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-year impact of praziquantel treatment for Schistosoma japonicum infection in China: re-infection, subclinical disease and fibrosis marker measurements.
    Li YS; Sleigh AC; Ross AG; Li Y; Williams GM; Tanner M; McManus DP
    Trans R Soc Trop Med Hyg; 2000; 94(2):191-7. PubMed ID: 10897367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversibility of Schistosoma mansoni-associated morbidity after yearly mass praziquantel therapy: ultrasonographic assessment.
    Boisier P; Ramarokoto CE; Ravaoalimalala VE; Rabarijaona L; Serieye J; Roux J; Esterre P
    Trans R Soc Trop Med Hyg; 1998; 92(4):451-3. PubMed ID: 9850407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schistosomiasis japonica and childhood nutritional status in northeastern Leyte, the Philippines: a randomized trial of praziquantel versus placebo.
    McGarvey ST; Aligui G; Graham KK; Peters P; Olds GR; Olveda R
    Am J Trop Med Hyg; 1996 May; 54(5):498-502. PubMed ID: 8644905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sorafenib and praziquantel synergistically attenuate Schistosoma japonicum-induced liver fibrosis in mice.
    Ma Z; Liu X; Dong H; Xia D; Wang L; Chen Y; Xiong Y
    Parasitol Res; 2018 Sep; 117(9):2831-2839. PubMed ID: 29946766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Praziquantel in the treatment of hepatosplenic schistosomiasis: biochemical disease markers indicate deceleration of fibrogenesis and diminution of portal flow obstruction.
    Zwingenberger K; Richter J; Vergetti JG; Feldmeier H
    Trans R Soc Trop Med Hyg; 1990; 84(2):252-6. PubMed ID: 2117787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of repeated praziquantel treatment on schistosomiasis mekongi morbidity as detected by ultrasonography.
    Chigusa Y; Ohmae H; Otake H; Keang H; Sinuon M; Saem C; Socheat D; Matsuda H
    Parasitol Int; 2006 Dec; 55(4):261-5. PubMed ID: 16893676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on resistance of Schistosoma to praziquantel XIII resistance of Schistosoma japonicum to praziquantel is experimentally induced in laboratory].
    Liang YS; Li HJ; Dai JR; Wang W; Qu GL; Tao YH; Xing YT; Li YZ; Qian K; Wei JY
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Dec; 23(6):605-10. PubMed ID: 22379812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver morbidity due to Schistosoma mekongi in Cambodia after seven rounds of mass drug administration.
    Keang H; Odermatt P; Odermatt-Biays S; Cheam S; Degrémont A; Hatz C
    Trans R Soc Trop Med Hyg; 2007 Aug; 101(8):759-65. PubMed ID: 17568642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Praziquantel pharmacokinetics and side effects in Schistosoma japonicum-infected patients with liver disease.
    Watt G; White NJ; Padre L; Ritter W; Fernando MT; Ranoa CP; Laughlin LW
    J Infect Dis; 1988 Mar; 157(3):530-5. PubMed ID: 3125260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic effect of resveratrol as well as resveratrol combined with praziquantel on the liver fibrosis due to Schistosoma japonicum infection in mice].
    Chen Y; Xiao Z
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2013 Oct; 31(5):337-41. PubMed ID: 24818384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Praziquantel in treatment of cerebral schistosomiasis.
    Watt G; Adapon B; Long GW; Fernando MT; Ranoa CP; Cross JH
    Lancet; 1986 Sep; 2(8506):529-32. PubMed ID: 2875279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatosplenic schistosomiasis presenting as spontaneous hemoperitoneum in a Filipino immigrant.
    Okamoto K; Brown JD
    Am J Med Sci; 2013 Oct; 346(4):334-7. PubMed ID: 23588267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue inhibitor of matrix-metalloprotease-1 predicts risk of hepatic fibrosis in human Schistosoma japonicum infection.
    Fabre V; Wu H; PondTor S; Coutinho H; Acosta L; Jiz M; Olveda R; Cheng L; White ES; Jarilla B; McGarvey ST; Friedman JF; Kurtis JD
    J Infect Dis; 2011 Mar; 203(5):707-14. PubMed ID: 21199883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.